Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Jardiance
Active Ingredient:	Empagliflozin 10mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Boehringer Ingelheim (NZ) Limited
Manufacturers:	Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany Boehringer Ingelheim Hellas Single Member S.A., Koropi Attiki, Greece

*Product:*	Jardiance
Active Ingredient:	Empagliflozin 25mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Boehringer Ingelheim (NZ) Limited
Manufacturers:	Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany Boehringer Ingelheim Hellas Single Member S.A., Koropi Attiki, Greece

Dated this 20th day of June 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule